U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H6N2O2
Molecular Weight 162.1454
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FENADIAZOLE

SMILES

OC1=CC=CC=C1C2=NN=CO2

InChI

InChIKey=OINXXHYENYVYPB-UHFFFAOYSA-N
InChI=1S/C8H6N2O2/c11-7-4-2-1-3-6(7)8-10-9-5-12-8/h1-5,11H

HIDE SMILES / InChI
Molecular Formula C8H6N2O2
Molecular Weight 162.1454
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Fenadiazole is a sedative/hypnotic drug. It has a a unique oxadiazole-based structure. It used to be manufactured by the French pharmaceutical company Laboratoires Jacques Logeais.

CNS Activity

CNS Active
3,913

Originator

Maillard, J. et al.
1

Approval Year

Unknown
139,594

Conditions

ConditionModalityTargetsHighest PhaseProduct
Insomnia
108
 Primary
Not Provided
504
Hypnazol

PubMed

Patents

FR M379
1
GB902388
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
8YX6HIZ0IP
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966